Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

239
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diphtheria outbreak, Northern Territory of Australia, 2025 to 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Remote regions, rapid recognition: performance and timeliness of BIOFIRE FilmArray BCID2 for diagnosing bloodstream infection in remote northern Australia.

Journal of clinical microbiology·2026
Same author

Epidemiology, Clinical Features, and Outcomes of Chronic Melioidosis in the Top End of Australia's Northern Territory, 1989-2023.

Open forum infectious diseases·2026
Same author

Throat and rectal swabs to diagnose melioidosis: utility or futility?

Journal of clinical microbiology·2026
Same author

Global dispersal of Burkholderia pseudomallei and the evolving endemicity of melioidosis in the United States of America.

PLoS neglected tropical diseases·2026
Same author

Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 Epidemic.

The Journal of infectious diseases·2026
Same journal

Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme.

Australian prescriber·2026
Same journal

Capivasertib for locally advanced or metastatic breast cancer.

Australian prescriber·2026
Same journal

Diagnosis and management of irritable bowel syndrome.

Australian prescriber·2026
Same journal

Stopping antidepressants: when and how.

Australian prescriber·2026
Same journal

Emergency contraception: an overview.

Australian prescriber·2026
Same journal

Sodium valproate: balancing benefits and risks especially in people of childbearing potential.

Australian prescriber·2026
See all related articles

Related Experiment Video

Updated: Jul 9, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K

Testing for COVID-19: a 2023 update.

Ella M Meumann1, Jennifer Mb Robson1

  • 1Sullivan Nicolaides Pathology, Bowen Hills, Brisbane.

Australian Prescriber
|December 6, 2023
PubMed
Summary
This summary is machine-generated.

Nucleic acid amplification tests (NAATs) are more sensitive for detecting SARS-CoV-2 than rapid antigen tests (RATs). RATs are convenient for COVID-19 diagnosis, but negative results may require confirmation with NAATs or repeat RATs.

Keywords:
SARS-CoV-2genomicsnucleic acid amplification testspolymerase chain reactionrapid antigen testvariants of concern

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.2K
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.6K

Related Experiment Videos

Last Updated: Jul 9, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.2K
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.6K

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Nucleic acid amplification tests (NAATs), including polymerase chain reaction (PCR), are the gold standard for diagnosing acute COVID-19 due to high sensitivity.
  • Rapid antigen tests (RATs) are widely used for COVID-19 diagnosis owing to their convenience, speed, and high specificity, especially within seven days of symptom onset.
  • Both NAATs and RATs have limitations; NAATs can remain positive post-infection, and RAT sensitivity can decrease over time.

Purpose of the Study:

  • To compare the diagnostic utility of NAATs and RATs for SARS-CoV-2 detection.
  • To elucidate the interpretation of antibody test results in the context of COVID-19 vaccination and infection.
  • To highlight the clinical implications of test selection and result interpretation for COVID-19 management.

Main Methods:

  • Review of diagnostic performance characteristics of NAATs and RATs for SARS-CoV-2.
  • Analysis of factors influencing test sensitivity and specificity.
  • Evaluation of serological markers, including spike and nucleocapsid antibodies, for distinguishing vaccination from infection.

Main Results:

  • NAATs demonstrate higher sensitivity for SARS-CoV-2 detection compared to RATs.
  • RATs are valuable for rapid COVID-19 diagnosis, with peak sensitivity within the first week of symptoms.
  • A negative RAT result may necessitate confirmatory testing via NAAT or repeat RAT; antibody presence indicates vaccination or infection, with nucleocapsid antibodies suggesting prior infection.

Conclusions:

  • NAATs remain the gold standard for acute COVID-19 diagnosis, while RATs offer a practical alternative for rapid screening.
  • Understanding the kinetics of viral shedding and antibody responses is crucial for accurate COVID-19 diagnosis and management.
  • Further development of readily available neutralizing antibody tests is needed to assess immunity effectively.